Alzheimer’s Association. Alzheimer’s disease facts and figures. Alzheimers Dement. 2022;18(4):700–89.

Article  Google Scholar 

Nianogo RA, Rosenwohl-Mack A, Yaffe K, Carrasco A, Hoffmann CM, Barnes DE. Risk factors associated with alzheimer disease and related dementias by sex and race and ethnicity in the US. JAMA Neurol. 2022;79(6):584–91.

Article  PubMed  PubMed Central  Google Scholar 

Heun R, Schoepf D, Potluri R, Natalwala A. Alzheimer’s disease and co-morbidity: increased prevalence and possible risk factors of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry. 2013;28(1):40–8.

Article  CAS  PubMed  Google Scholar 

Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179(2):312–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease. Neurology. 1993;43(8):1467–72.

Article  CAS  PubMed  Google Scholar 

Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4):213–27.

Article  PubMed  PubMed Central  Google Scholar 

Haass C, Koo EH, Mellon A, Hung AY, Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 1992;357(6378):500–3.

Article  CAS  PubMed  Google Scholar 

Theuns J, Del-Favero J, Dermaut B, van Duijn CM, Backhovens H, Van den Broeck MV, et al. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer’s disease and variable expression. Hum Mol Genet. 2000;9(3):325–31.

Article  CAS  PubMed  Google Scholar 

Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer’s disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer’s disease type 3 gene. Nature. 1995;376(6543):775–8.

Article  CAS  PubMed  Google Scholar 

Sherrington R, Froelich S, Sorbi S, Campion D, Chi H, Rogaeva EA, et al. Alzheimer’s disease associated with mutations in presenilin 2 is rare and variably penetrant. Hum Mol Genet. 1996;5(7):985–8.

Article  CAS  PubMed  Google Scholar 

Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, et al. A familial Alzheimer’s disease locus on chromosome 1. Science. 1995;269(5226):970–3.

Article  CAS  PubMed  Google Scholar 

Ou-Yang MH, Kurz JE, Nomura T, Popovic J, Rajapaksha TW, Dong H, et al. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci Transl Med. 2018;10(459).

Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735–41.

Article  CAS  PubMed  Google Scholar 

Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, Biswas A. Metabolic risk factors of sporadic Alzheimer’s disease: implications in the pathology, pathogenesis and treatment. Aging Dis. 2015;6(4):282–99.

Article  PubMed  PubMed Central  Google Scholar 

van der Flier WM, Scheltens P. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry. 2005;76(5):v2-7.

Article  PubMed  PubMed Central  Google Scholar 

LaFerla FM, Green KN. Animal models of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(11).

Sharma VK, Mehta V, Singh TG. Alzheimer’s disorder: epigenetic connection and associated risk factors. Curr Neuropharmacol. 2020;18(8):740–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111–28.

Article  PubMed  PubMed Central  Google Scholar 

Aikawa T, Holm ML, Kanekiyo T. ABCA7 and pathogenic pathways of Alzheimer's disease. Brain Sci. 2018;8(2).

Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4, and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309(14):1483–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glymour MM, Manly JJ. Lifecourse social conditions and racial and ethnic patterns of cognitive aging. Neuropsychol Rev. 2008;18(3):223–54.

Article  PubMed  Google Scholar 

Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23(15):5293–300.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dolinoy DC. Epigenetic gene regulation: early environmental exposures. Pharmacogenomics. 2007;8(1):5–10.

Article  CAS  PubMed  Google Scholar 

Tecalco-Cruz AC, Ramirez-Jarquin JO, Alvarez-Sanchez ME, Zepeda-Cervantes J. Epigenetic basis of Alzheimer disease. World J Biol Chem. 2020;11(2):62–75.

Article  PubMed  PubMed Central  Google Scholar 

Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J. Epigenetic changes in Alzheimer’s disease: decrements in DNA methylation. Neurobiol Aging. 2010;31(12):2025–37.

Article  CAS  PubMed  Google Scholar 

Chang L, Wang Y, Ji H, Dai D, Xu X, Jiang D, et al. Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer’s disease. PLoS ONE. 2014;9(11): e110773.

Article  PubMed  PubMed Central  Google Scholar 

Declerck K, Vanden BW. Characterization of blood surrogate immune-methylation biomarkers for immune cell infiltration in chronic inflammaging disorders. Front Genet. 2019;10:1229.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karlsson IK, Ploner A, Wang Y, Gatz M, Pedersen NL, Hagg S. Apolipoprotein E DNA methylation and late-life disease. Int J Epidemiol. 2018;47(3):899–907.

Article  PubMed  PubMed Central  Google Scholar 

Madrid A, Hogan KJ, Papale LA, Clark LR, Asthana S, Johnson SC, et al. DNA hypomethylation in blood links B3GALT4 and ZADH2 to Alzheimer’s disease. J Alzheimers Dis. 2018;66(3):927–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang E, Wang M, Guo L, Fullard JF, Micallef C, Bendl J, et al. Genome-wide methylomic regulation of multiscale gene networks in Alzheimer’s disease. Alzheimers Dement. 2023;19(8):3472–95.

Article  CAS  PubMed  Google Scholar 

Kim BH, Vasanthakumar A, Li QS, Nudelman KNH, Risacher SL, Davis JW, et al. Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer’s disease. Alzheimers Dement (Amst). 2022;14(1): e12354.

Article  PubMed  Google Scholar 

Peng X, Zhang W, Cui W, Ding B, Lyu Q, Wang J. ADmeth: a manually curated database for the differential methylation in Alzheimer’s disease. IEEE/ACM Trans Comput Biol Bioinform. 2023;20(2):843–51.

Article  CAS  PubMed  Google Scholar 

Jima DD, Skaar DA, Planchart A, Motsinger-Reif A, Cevik SE, Park SS, et al. Genomic map of candidate human imprint control regions: the imprintome. Epigenetics. 2022;17(13):1920–43.

Article  PubMed  PubMed Central  Google Scholar 

Smallwood SA, Kelsey G. De novo DNA methylation: a germ cell perspective. Trends Genet. 2012;28(1):33–42.

Article  CAS  PubMed  Google Scholar 

Cowley M, Oakey RJ. Resetting for the next generation. Mol Cell. 2012;48(6):819–21.

Article  CAS  PubMed  Google Scholar 

Mandy M, Nyirenda M. Developmental Origins of Health and Disease: the relevance to developing nations. Int Health. 2018;10(2):66–70.

Article  PubMed  PubMed Central